US Patent Litigations are now available. Check here

IP Verse

Macrocycles As Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions Thereof, Their Use In The Treatment Of Cycstic Fibrosis, And Process For Making Them

EP3752510

VERTEX PHARMACEUTICALS INCORPORATED
Application Number
EP19707648A
Filing Date
Feb 14, 2019
Status
Granted And Under Opposition
Nov 4, 2022
Grant Date
Dec 7, 2022
External Links
Slate, Register, Google Patents

Biblio Summary

The patent EP3752510B1 was granted on Dec 7, 2022 by Vertex Pharmaceuticals Incorporated The patent is currently Granted And Under Opposition.

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

TEVA PHARMACEUTICAL INDUSTRIESSep 7, 2023ADMISSIBLE

Other Patents of Vertex Pharmaceuticals Incorporated

The table below shows the patents of Vertex Pharmaceuticals Incorporated that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP2464337Pharmaceutical Composition And Administrations ThereofJun 26, 20241
EP2914248Pharmaceutical Compositions For The Treatment Of Cftr Mediated DiseasesOct 18, 20231
EP3925607Pharmaceutical Compositions For The Treatment Of Cystic Fibrosis Transmembrane Conductance Regulator Mediated DiseasesJun 28, 20231

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents